BRAINSTORM CELL THERAPUTC
BCLI
BCLI was delisted on the 17th of July, 2025.
32 hedge funds and large institutions have $1.09M invested in BRAINSTORM CELL THERAPUTC in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 6 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
95% more capital invested
Capital invested by funds: $560K → $1.09M (+$531K)
10.86% more ownership
Funds ownership: 7.09% → 17.95% (+11%)
6% less funds holding
Funds holding: 34 → 32 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.22M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$10K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$8.59K |
| 4 |
BSB
Bangor Savings Bank
Bangor,
Maine
|
+$471 |
| 5 |
Jones Financial Companies
Des Peres,
Missouri
|
+$382 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$89.8K |
| 2 |
HF
HRT Financial
New York
|
-$45K |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$13.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.7K |
| 5 |
Citigroup
New York
|
-$4.47K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CWM
26
Centricity Wealth Management
Westerville,
Ohio
| $25 | – | – | – |
|
|
CIAS
27
CBIZ Investment Advisory Services
Independence,
Ohio
| $16 | – | – | – |
|
|
WIM
28
Westside Investment Management
Santa Monica,
California
| $16 | – | – | – |
|
29
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $13 | – | – | – |
|
|
CA
30
CoreCap Advisors
Southfield,
Michigan
| $10 | – | – | – |
|
|
BWL
31
Bogart Wealth LLC
Mclean,
Virginia
| $3 | – | – | – |
|
|
HF
32
HRT Financial
New York
| – | -$45K | -20,022 | Closed |
|
|
IC
33
Ikarian Capital
Dallas,
Texas
| – | -$13.7K | -6,016 | Closed |
|
|
34
Citigroup
New York
| – | -$4.47K | -1,971 | Closed |
|
|
AWM
35
Avior Wealth Management
Omaha,
Nebraska
| – | -$1.7K | -747 | Closed |
|
|
T
36
Transce3nd
Kyle,
Texas
| – | -$336 | -148 | Closed |
|
|
EWA
37
EverSource Wealth Advisors
Birmingham,
Alabama
| – | -$320 | -141 | Closed |
|
BCLI Hedge Fund Activity: Q1 2025 in Review
32 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in BRAINSTORM CELL THERAPUTC (BCLI) for Q1 2025, worth a combined $1.09M — up 95% from $560K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BCLI and 4 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 7 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.22M. The largest seller was Vanguard Group, cutting an estimated $89.8K.
- 32 institutional investors held BRAINSTORM CELL THERAPUTC (BCLI) as of Q1 2025, down from 34 in Q4 2024.
- Funds reported $1.09M of BRAINSTORM CELL THERAPUTC stock for Q1 2025, up 95% quarter-over-quarter.
- 4 funds opened new BRAINSTORM CELL THERAPUTC positions in Q1 2025 and 6 closed out, a net change of -2 holders.
- The largest BRAINSTORM CELL THERAPUTC buyer in Q1 2025 was Armistice Capital, an estimated $1.22M added.
- The largest BRAINSTORM CELL THERAPUTC seller in Q1 2025 was Vanguard Group, an estimated $89.8K sold.
Based on aggregated 13F filings for Q1 2025.